Resin Salve Versus Honey Treatment in Wound Care

Kuopio University Hospital

Status: Completed

Conditions: Wound Healing; Wound Infection

Treatments: Device: Activon Tube 25 g; Device: Abilar 10% resin salve

Study type: Interventional

Funder types: Other

Identifiers

NCT01868412

KUH15101075

Details and patient eligibility

About

In recent years, salve prepared from Norway spruce (Picea abies) resin and refined honey from manuka myrtle (Leptospermum scoparium), has successfully been used in medical context to treat both acute and chronic surgical wounds. The objective of this prospective, randomized and controlled clinical trial is to investigate healing rate and healing time of surgical wounds in patients, who have undergone peripheral vascular surgery, and whose complicated wounds are candidate for topical treatment with the resin or honey. In addition, factors contributing with delayed wound healing, antimicrobial properties, safety and cost-effectiveness of the resin salve and medical honey will be analyzed.

Enrollment: 40 patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Infected of non-infected acute or chronic wound after vascular surgery.
• Need for topical wound care.
• Need for wound healing follow-up at the surgical outpatient department.

Exclusion criteria

• Life expectancy less than 6 months.
• Advanced malignant disease.
• Need for extensive surgical wound revision or skin transplantation.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

Resin & honey

Experimental group

Description:

Abilar 10% resin salve

Treatment:

Device: Abilar 10% resin salve

Resin vs. honey

Active Comparator group

Description:

Activon Tube 25 g

Treatment:

Device: Activon Tube 25 g